vs

Side-by-side financial comparison of BioNTech SE (BNTX) and Clean Energy Fuels Corp. (CLNE). Click either name above to swap in a different company.

BioNTech SE is the larger business by last-quarter revenue ($1.5B vs $117.6M, roughly 12.9× Clean Energy Fuels Corp.). BioNTech SE runs the higher net margin — -1.9% vs -10.6%, a 8.7% gap on every dollar of revenue.

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.

Bloom Energy is an American public company that designs and manufactures solid oxide fuel cells (SOFCs) which independently produce electricity onsite for power generation in data centers, manufacturing, and other commercial sectors. Founded in 2001 and headquartered in San Jose, California; its fuel cell technology generates electricity through a chemical conversion process, which differs from most other power sources reliant on combustion, and can use natural gas, biogas or hydrogen as fuel...

BNTX vs CLNE — Head-to-Head

Bigger by revenue
BNTX
BNTX
12.9× larger
BNTX
$1.5B
$117.6M
CLNE
Higher net margin
BNTX
BNTX
8.7% more per $
BNTX
-1.9%
-10.6%
CLNE

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
BNTX
BNTX
CLNE
CLNE
Revenue
$1.5B
$117.6M
Net Profit
$-28.7M
$-12.4M
Gross Margin
Operating Margin
-3.1%
-2.5%
Net Margin
-1.9%
-10.6%
Revenue YoY
0.0%
Net Profit YoY
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BNTX
BNTX
CLNE
CLNE
Q1 26
$117.6M
Q4 25
$112.3M
Q3 25
$1.5B
$106.1M
Q2 25
$260.8M
$102.6M
Q1 25
$103.8M
Q4 24
$109.3M
Q3 24
$1.2B
$104.9M
Q2 24
$98.0M
Net Profit
BNTX
BNTX
CLNE
CLNE
Q1 26
$-12.4M
Q4 25
$-43.0M
Q3 25
$-28.7M
$-23.8M
Q2 25
$-386.6M
$-20.2M
Q1 25
$-135.0M
Q4 24
$-30.2M
Q3 24
$198.1M
$-18.2M
Q2 24
$-16.3M
Operating Margin
BNTX
BNTX
CLNE
CLNE
Q1 26
-2.5%
Q4 25
-9.5%
Q3 25
-3.1%
-12.8%
Q2 25
-192.1%
-9.0%
Q1 25
-121.7%
Q4 24
-11.8%
Q3 24
0.8%
-8.1%
Q2 24
-5.7%
Net Margin
BNTX
BNTX
CLNE
CLNE
Q1 26
-10.6%
Q4 25
-38.3%
Q3 25
-1.9%
-22.4%
Q2 25
-148.2%
-19.7%
Q1 25
-130.1%
Q4 24
-27.6%
Q3 24
15.9%
-17.3%
Q2 24
-16.6%
EPS (diluted)
BNTX
BNTX
CLNE
CLNE
Q1 26
Q4 25
$-0.21
Q3 25
$-0.11
Q2 25
$-0.09
Q1 25
$-0.60
Q4 24
$-0.14
Q3 24
$-0.08
Q2 24
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BNTX
BNTX
CLNE
CLNE
Cash + ST InvestmentsLiquidity on hand
$70.8M
Total DebtLower is stronger
$54.0K
Stockholders' EquityBook value
$563.7M
Total Assets
$1.0B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BNTX
BNTX
CLNE
CLNE
Q1 26
$70.8M
Q4 25
$156.1M
Q3 25
$232.2M
Q2 25
$240.8M
Q1 25
$226.6M
Q4 24
$217.5M
Q3 24
$243.5M
Q2 24
$249.3M
Total Debt
BNTX
BNTX
CLNE
CLNE
Q1 26
$54.0K
Q4 25
$226.8M
Q3 25
$284.3M
Q2 25
$277.9M
Q1 25
$271.6M
Q4 24
$265.4M
Q3 24
$264.1M
Q2 24
$263.0M
Stockholders' Equity
BNTX
BNTX
CLNE
CLNE
Q1 26
$563.7M
Q4 25
$559.4M
Q3 25
$585.2M
Q2 25
$590.8M
Q1 25
$596.7M
Q4 24
$713.3M
Q3 24
$724.8M
Q2 24
$723.0M
Total Assets
BNTX
BNTX
CLNE
CLNE
Q1 26
$1.0B
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.2B
Q3 24
$1.2B
Q2 24
$1.2B
Debt / Equity
BNTX
BNTX
CLNE
CLNE
Q1 26
0.00×
Q4 25
0.41×
Q3 25
0.49×
Q2 25
0.47×
Q1 25
0.46×
Q4 24
0.37×
Q3 24
0.36×
Q2 24
0.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BNTX
BNTX

Segment breakdown not available.

CLNE
CLNE

Product revenue$102.9M88%
Service revenue$14.7M12%

Related Comparisons